Hos patienter med dekompenseret leversygdom, var de hyppigst rapportede uønskede reaktioner i løbet af op til 203 uger med adefovirdipivoxilbehandling forhøjet kreatinin (7%) og asteni (5%).
In patients with decompensated liver disease, the most frequently reported adverse reactions during up to 203 weeks of adefovir dipivoxil therapy were increased creatinine (7%) and asthenia (5%).